TY - JOUR T1 - Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1 JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 810 LP - 816 DO - 10.1097/IGC.0000000000000694 VL - 26 IS - 5 AU - Lingyun Zhang AU - Xin Zhan AU - Dingding Yan AU - Zhihua Wang Y1 - 2016/06/01 UR - http://ijgc.bmj.com/content/26/5/810.abstract N2 - Objective The aims of this study were to discover if increased circulating microRNA-21 (miR-21) expression in serum is associated with lymph node metastasis in patients with cervical cancer and look further into the molecular mechanism of these. Whole-blood samples from 89 patients who have been histopathologically confirmed as having cervical cancer and 20 control subjects were collected, and then the association between lymph node metastasis and the level of circulating miR-21 was compared. Then cervical cancer cell lines HeLa (HPV-18 DNA+, E6/E7RNA+) and HT-3 (HPV DNA−, E6/E7RNA−) were used to confirm the interaction between miR-21 and RASA1. The role of RASA1 in cervical cancer cell migration was also studied in HeLa. Increased circulating miR-21 expression in serum is associated with lymph node metastasis in patients with cervical cancer. MicroRNA-21 reduces RASA1 expression in cervical cancer cell lines and promotes cervical cancer cell migration via RASA1. Furthermore, Ras-induced epithelial-mesenchymal transition contributes to miR-21/RASA1 axis promoting cervical cancer cell migration. Circulating miR-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer, and inhibition of miR-21/RASA1 axis could be a possible strategy to restrain migration of cervical cancer. ER -